-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Reiterates Buy on TransMedics Group, Maintains $120 Price Target

Benzinga·09/08/2026 14:14:42
Listen to the news
TD Cowen analyst Joshua Jennings reiterates TransMedics Group (NASDAQ:TMDX) with a Buy and maintains $120 price target.